title: Bone loss with exemestane: Is the jury still out?
authors.forename: Angela M
authors.initials: AM
authors.lastname: Cheung
authors.forename: George
authors.initials: G
authors.lastname: Tomlinson
authors.forename: Paul E
authors.initials: PE
authors.lastname: Goss
mesh_terms: D000730:Androstadienes / Q000009:adverse effects*; D000970:Antineoplastic Agents / Q000009:adverse effects*; D015519:Bone Density / Q000187:drug effects*; D001943:Breast Neoplasms; D005260:Female; D005269:Femur; D006801:Humans; D017698:Postmenopause; D015203:Reproducibility of Results
chemical_list: D000730:Androstadienes; D000970:Antineoplastic Agents; C056516:exemestane